ARTICLE | Company News
Acusphere, Nycomed Group A/S deal
April 13, 2009 7:00 AM UTC
The partners terminated a 2004 deal granting Nycomed exclusive rights to develop and commercialize Acusphere's Imagify perflubutane in the EU, Turkey, Russia and the CIS. The reason for the terminati...